Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 14/20 | 0.48 |
| ▸ | P2RY6 | Q15077 | 11/20 | 0.48 |
| ▸ | P2RY4 | P51582 | 6/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31381448 | 1.00 | P2RY2 (0.48) | P2RY2P2RY6P2RY4 | |
| SCHEMBL26883180 | 1.00 | P2RY2 (0.48) | P2RY2P2RY6P2RY4 | |
| SCHEMBL31725092 | 0.98 | P2RY6 (0.45) | P2RY2P2RY6P2RY4 | |
| SCHEMBL31725148 | 0.91 | DNPH1 (0.46) | P2RY6 | |
| SCHEMBL25173530 | 0.90 | P2RY6 (0.50) | P2RY2P2RY6P2RY4 | |
| SCHEMBL17814786 | 0.88 | P2RY2 (0.55) | P2RY2P2RY6P2RY4 | |
| SCHEMBL16094950 | 0.88 | P2RY2 (0.55) | P2RY2P2RY6P2RY4 | |
| SCHEMBL22001227 | 0.88 | P2RY2 (0.55) | P2RY2P2RY6P2RY4 | |
| SCHEMBL24414841 | 0.88 | P2RY2 (0.55) | P2RY2P2RY6P2RY4 | |
| SCHEMBL14885788 | 0.88 | P2RY2 (0.55) | P2RY2P2RY6P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230383287-A1 | ACETYLATED RIBONUCLEIC ACIDS AND USES THEREOF | HELIX NANOTECHNOLOGIES INC | 2023-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230383287-A1 | ACETYLATED RIBONUCLEIC ACIDS AND USES THEREOF | NSUN2, NSUN3, ADAR | P2RY2 3581/4885P2RY6 3557/4885P2RY4 3754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.